 |
| Dr. Candilee Butler, MD My Breast Care Surgeon Medical School:
University Of Toledo College Of Medicine
Toledo, OH, United States Graduated: 1982 Residency Hospital:
Med College Ohio
Toledo, OH, USA Year completed: 1988 Internship Hospital:
Med College Ohio
Toledo, OH, US Year completed: 1983
Dr. Candilee Butler MD practices general
surgery in Toledo, OH. Dr. Butler graduated with an MD 29 years ago.
Specialties:
General Surgery- Board Certified
Most Common Procedures:
Breast Tissue Expander InsertionMastectomy Lymph Node Biopsy Lymph Node Removal Breast Lesion Removal Diagnostic Breast Procedure |
 |
Dr Iman Mohamed, MD
My Medical Oncologist
University of Toledo Medical Center Toledo, OH- Current position
Internist, Medical Oncologist- Board Certified
Professor, Medicine
Chief, Division of Hematology/Oncology
Medical Director, Breast Center
Medical Director of the Comprehensive Breast Center
at the UTMC Cancer Institute Medical School:
Kuwait University
Health Sciences Centre
Faculty of Medicine
Satfat, Kuwait
Graduated 1985
Residency Hospital:
St. Joseph Mercy Hospital
Pontiac, MI
Internal Medicine
Year completed: 1993
Fellowship Hospital:
William Beaumont Hospital
Royal Oak, Michigan
Oncology
Year completed: 1993
Dr. Iman Mohamed, MD practices
Hematology in Toledo, OH. Dr Mohamed graduated with a MD 26 years ago.
Specialties:
. Hematology
. Oncology
Ohio licensed since 1999
Special Interests:
Clinical: Breast Cancer/Genetic Counseling
Research: Novel Therapy for Metastatic Breast Cancer and Locally Advanced Breast Cancer
|
My Chemotherapy Nurses
 | ||||
Michelle Bragazzi, RN, BS
My Clodronate Study Coordinator
University of Toledo Medical Center, Toledo,OH-
Jacobson Center for Clinical Research
Position: Oncology Research Coordinator
My Clinical Study:
Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
The purpose of this study is to compare overall survival in patients receiving clodronate versus ibandronate versus zoledronic acid as adjuvant therapy for breast cancer in an attempt to prevent bone metastasis. Bisphosphonates are a diverse group of compounds, which have profound effects on bone mineralization and resorption. This study was for a confirmed diagnosis of primary invasive adenocarcinoma of the breast (Stage I, II, III) with no evidence of metastatic disease, primary disease within the breast must be resected, either with mastectomy or breast sparing surgery, receiving standard (systemic) adjuvant therapy for breast cancer, at least 18 years of age and female. This study is ongoing but is now closed to participants.
Principal Investigator: Iman Mohamed, M.D.
|
 |
Dr Jeffrey Alan Forquer, MD
My Radiation Oncologist
Medical School:
The Ohio State University College of Medicine
Columbus, OH
Year completed 2004
Internship: Riverside Methodist Hospital Residency: Indiana University Dr. Jeffrey Alan Forquer MD practices radiology in Maumee OH., Sylvania OH., Oregon OH. and Toledo OH. Dr. Forquer graduated with an MD 7 years ago.
Specialties:
. Radiology- Board Certified
. Radiation of Oncology
Ohio Licensed
|
